Developer docs
API playgroundTry for free, no card

Search company profiles

Facet Life Sciences

Full company profile

uuid00096aw

Namestring
Facet Life Sciences
Legal namestring
Facet Life Sciences
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Facet Life Sciences is a U.S.-based regulatory affairs and product development strategy consultancy founded in 2013 (originally as Virtual Regulatory Solutions, Inc., rebranded in 2014) and headquartered in Wayne, Pennsylvania. The firm serves small and emerging life sciences companies — primarily emerging biotech, small pharmaceutical developers, and medical device innovators — providing integrated advisory services from early preclinical planning through FDA approval, commercialization, and asset divestiture. Its service portfolio spans eight flagship offerings (US Agent Services, Gap Analysis, Strategic Regulatory and Development Guidance, FDA Meeting Consulting, Medical Writing of Submission Documents, Regulatory Submission Leadership, Strategic Statistical Services, and Asset Valuation and Optimization) plus specialty practices in ophthalmology, oncology, PET radiopharmaceuticals, psychedelic therapeutics, and rare/ultra-rare disease innovation.

The firm operates a virtual delivery model with 30+ employees distributed across 14 U.S. states, supported by a curated 20+ partner ecosystem that extends delivery into CMC manufacturing, clinical CRO operations (Lexitas for ophthalmology, Cannovation for psychedelics, Alithia for Australia, Veramed for biometrics), legal and IP, and the KIVO submission management platform (originally Gemstone, internally developed and later spun off as an independent software company). Revenue is generated exclusively through professional services engagements — project-based, retainer, or embedded-team structures — priced via custom scoping of regulatory, CMC, nonclinical, and clinical needs, with no published rate cards. The firm has supported more than 250 companies through FDA formal meetings and 40+ companies through IND/IDE, NDA/BLA, and device submissions.

The company's core technology is its accumulated institutional regulatory expertise rather than a proprietary software platform: proprietary gap analysis frameworks, integrated regulatory strategy methodologies, and 300+ years of combined team experience drawn from FDA-touching organizations (former leaders from Wyeth, Sanofi, Bristol-Myers Squibb, Eli Lilly, and Schering-Plough). Go-to-market is sales-led and consultative, targeting C-suite and executive leadership at small pharma and biotech companies; marketing relies on thought-leadership content (active blog, published Springer reference books, case studies), industry conferences (DIA, RAPS, SNMMI), and community engagement rather than paid acquisition. Distribution is entirely direct, U.S.-focused given the FDA regulatory specialization, with international reach delivered only through partner channels.

Short descriptiontext

Facet Life Sciences is a U.S.-based regulatory affairs and product development strategy consultancy serving small biotech, pharmaceutical, and medical device companies. It provides integrated advisory services spanning gap analysis, FDA meeting preparation, regulatory submissions, statistics, medical writing, and asset valuation, with specialty practices in ophthalmology, oncology, radiopharmaceuticals, psychedelics, and rare diseases.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPhiladelphia, United States
HQ citystring
Philadelphia
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory affairs consulting, FDA submission strategy, drug development consulting, medical device regulatory, biotech regulatory services
Industry3 codes
PRIMARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAKAL
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code3 codes
  • Other Scientific and Technical Consulting Services54169
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Commercial Physical & Biological Research8731
Product category
Regulatory Affairs Consulting
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Regulatory Consulting and Advisory Services
TypeProfessional Services
Description

Facet Life Sciences provides fee-for-service regulatory strategy, gap analysis, FDA meeting preparation, medical writing, regulatory submission leadership, and statistical consulting. Engagement models include project-based consulting, retainer arrangements, and embedded team support. Revenue is generated through professional service engagements billed by the project, hour, or program.

facetlifesciences.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Project-based professional services — custom scoping
ModelOtherBilling cadenceMulti-year contract
Notes

Services are quoted on a per-project, per-engagement basis. No public pricing tiers or rate cards. Contact-based sales with custom proposals tailored to each client's development program and goals.

facetlifesciences.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Facet Life Sciences is a regulatory affairs and product development strategy consulting firm that helps small biotech, emerging pharma, and medical device companies navigate FDA pathways from early development through approval and commercialization. Core engagements span US Agent Services, Gap Analysis, Strategic Regulatory & Development Guidance, FDA Meeting preparation, Medical Writing of regulatory submissions, Regulatory Submission Leadership (IND/IDE/NDA/BLA), Strategic Statistical Services, and Asset Valuation & Optimization, delivered on a project, retainer, or embedded-team basis.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Pivotal study database lock to NDA (approved) in six weeks
+5 more records
Product overview1 text field

Facet Life Sciences is a regulatory affairs and product development strategy partner for small biotech and emerging science companies. The company offers a comprehensive suite of integrated advisory services organized around flagship service pillars: US Agent Services, Gap Analysis, Strategic Regulatory & Development Guidance, FDA Meeting Consulting, Medical Writing of Submission Documents, Regulatory Submission Leadership, Strategic Statistical Services, and Asset Valuation and Optimization. The company also maintains specialty expertise in Ophthalmology, Oncology, PET Radiopharmaceutical Development, Psychedelic Therapeutics, and Rare Disease Innovation Support. Beyond core services, Facet has developed proprietary technology (KIVO submission management platform, formerly Gemstone) and publishes educational content including the FDA and Intellectual Property Strategies for Medical Device Technologies book.

Product and service10 records
1US Agent Services
CategoryRegulatory Services
Description

Liaises with the FDA on behalf of sponsors, serving as an experienced strategic US Agent that facilitates efficient collaboration and leverages decades of successful working relationships with FDA reviewers. Designed for non-US and emerging US companies that require a US-based regulatory point of contact with the FDA.

2Gap Analysis
CategoryRegulatory Services
Description

Identifies program gaps, risks, and potential risk mitigation strategies for regulatory submissions across nonclinical, CMC, clinical, regulatory, and tactical dimensions. Used by emerging life sciences companies preparing for FDA meetings, INDs, NDAs, or device submissions.

3Strategic Regulatory & Development Guidance
CategoryRegulatory Services
Description

Designs and executes effective regulatory, CMC, nonclinical, and clinical strategies that support end business goals, developing regulatory plans aligned with corporate objectives and resources. Targeted at small life sciences companies needing senior regulatory leadership without an in-house team.

4FDA Meeting Consulting
CategoryRegulatory Services
Description

Prepares companies for FDA meetings through rigorous preparation processes, authoring meeting requests, background packages, and coaching to ensure productive interactions with FDA reviewers. Used by sponsors preparing Type A/B/C, pre-IND, EOP, and other formal FDA meetings.

5Medical Writing of Submission Documents
CategoryRegulatory Services
Description

Authors and coordinates reviews for regulatory submissions on behalf of sponsors, including planning, preparation, QC, and finalization of documents written with the FDA reviewer in mind. Used by sponsors needing FDA-grade nonclinical, CMC, and clinical submission writing.

6Regulatory Submission Leadership
CategoryRegulatory Services
Description

Manages creation, review, and finalization of regulatory submissions for new drug/biologic applications (IND, NDA, BLA), medical device applications, and combination products. Used by small companies needing outsourced regulatory operations leadership for major submissions.

7Strategic Statistical Services
CategoryStrategic Statistical Services
Description

Applies advanced statistical principles and methodologies to accelerate development of drugs, biologics, medical devices, and combination products through innovative study designs and cutting-edge analytic techniques. Targeted at sponsors needing expert biostatistics and biometrics support.

8Asset Valuation and Optimization
CategoryStrategic & Commercial Services
Description

Helps companies know and grow the full potential of their asset at every development stage—from early-stage R&D through commercial launch—spanning market assessment, regulatory alignment, investor support, and pricing strategy. Used by emerging biotech and pharma teams preparing for investor outreach, partnerships, or divestiture.

9Ophthalmic Drug Development Services
CategorySpecialty Therapeutic Services
Description

Expert regulatory and development support for ophthalmology products including dry eye, glaucoma, meibomian gland dysfunction, wet AMD, uveitis, and rare ophthalmic diseases. Targeted at developers of ophthalmic drugs, biologics, devices, and combination products.

10Oncology Drug Development Services
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership21 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-06
Description

Facet Life Sciences and XCancer announced a strategic partnership to accelerate the development and approval of radiopharmaceutical therapies in oncology. The collaboration combines their expertise and infrastructure to streamline clinical trials and expand patient access to precision medicine. The partnership aims to simplify development and regulatory pathways for innovative theranostic therapies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nucleus RadioPharma is an end-to-end contract development and manufacturing organization (CDMO) partner dedicated to building robust and reliable clinical and commercial supply chains for targeted radiotherapies. Facet announced Nucleus as an official regulatory partner, providing clinical and commercial supply chain support for radiopharmaceutical programs.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Alithia Life Sciences is an Australian-owned boutique, full-service CRO launched to support pharmaceutical, biotechnology, device companies, and institutional research groups in the Australian region and beyond. Serves as Facet's regional partner for Australian clinical trial operations.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

A U.S.-based global clinical research organization offering full-service preclinical/clinical research and commercialization services. Specializes in non-traditional cannabinoid and psychedelic-based drugs. Serves as Facet's partner for psychedelic and cannabinoid therapeutic development programs.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Lexitas is a premier CRO dedicated exclusively to ophthalmology since 2011. Provides customized ophthalmic research solutions across all ophthalmology subspecialties. Serves as Facet's ophthalmology-specific clinical operations partner.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

TheranosticTrials.org is the premier global hub advancing cancer Theranostics, connecting every link in the Theranostic Trials Ecosystem. Facet partners with Theranostic Trials to provide regulatory expertise as part of the theranostic clinical trial ecosystem, including for radioligand therapy development.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Tranquil Clinical Research provides clinical trial, device, and drug development process services with ethics and the patient in mind. Serves as Facet's partner for clinical trial execution support.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Trialwise specializes in early phases of drug development, founded in 1999 by Beth Brinsdon. Provides high-level personalized service for start-up and small-to-midsize biotech companies. Serves as Facet's partner for early-phase clinical development.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

IDT Australia is an ASX-listed Contract Development and Manufacturing Organization (CDMO) based in Melbourne with over 50 years of experience in pharmaceutical manufacturing. Facilities audited by FDA, TGA, and Japanese MHLW. Serves as Facet's Australian manufacturing partner for oral and sterile injectable products.

10RoyalMount Labs (Pharmascience Inc.)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

RoyalMount is a CDMO operating from an FDA-approved site in Candiac, Canada. Capabilities span small molecules, large molecules, oligonucleotides, monoclonal antibodies (mAbs), and antibody-drug conjugates (ADCs). Serves as Facet's Canadian manufacturing partner.

facetlifesciences.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Asphalion is a leading regulatory affairs consultancy founded in 2000, providing high-quality services for the development and registration of innovative drugs. Serves as Facet's ex-US regulatory affairs partner for European regulatory support.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

cGMP Validation is a full-service validation/compliance firm established in 1997 serving pharmaceutical, biotech, biologics, medical device, and diagnostic industries. Provides validation IQ/OQ/PQ protocols and compliance documentation. Serves as Facet's GxP audit partner.

Strategic tierMinorTypeOthers
Description

Troutman Pepper Locke is a global law firm helping clients solve complex legal challenges in life sciences, including regulatory, intellectual property, and corporate matters. Serves as Facet's legal counsel partner for complex client matters.

14MedSurg PI
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

MedSurg PI provides medical affairs services for pharmaceutical, biotechnology, medical device, and related technology companies. Founded and led by experienced clinician-executives with backgrounds in medicine, surgery, technology, product commercialization, and clinical development. Serves as Facet's medical affairs partner.

facetlifesciences.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Attentive Science is an FDA-inspected, AAALAC-accredited premier global leader in GLP and non-GLP in-vivo pharmacokinetics, toxicology, and safety pharmacology services. Serves as Facet's nonclinical CRO partner.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Nosco is a full-service packaging solutions provider serving 400+ customers in healthcare with over 110 years of experience. Specializes in cartons, labels, inserts, and flexible packaging. Serves as Facet's packaging and printing partner.

Strategic tierMinorTypeOthers
Description

Potomac Law is an intellectual property law firm with attorneys across the United States. Serves as Facet's patent support partner.

Strategic tierMinorTypeOthers
Description

Volpe Koenig is a full-service IP law firm serving U.S. and global clients across varied industries and technologies. Provides strategic intellectual property counseling to protect valuable portfolios and assets. Serves as Facet's additional patent support partner.

19Red Nucleus
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Red Nucleus is the premier provider of learning, performance, and process solutions for the life sciences industry with more than 500 full-time employees. Serves as Facet's regulatory publishing and commercial/R&D training partner.

facetlifesciences.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

WAYS Pharmaceutical Services helps biopharmaceutical organizations prepare and submit research documents and supporting data to health authorities worldwide. Serves as Facet's regulatory submission preparation and advisory partner.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Veramed is a pioneering CRO providing next-level biometrics support across the drug development lifecycle. Certified B Corp providing transparent and collaborative statistical and programming solutions. Serves as Facet's end-to-end biometrics and CDISC/SEND partner.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pharmalex is a regulatory and pharmacovigilance consulting firm supporting biotech and pharma companies across FDA/EMA submissions, CMC, and clinical development. Directly comparable to Facet in regulatory services focus and small/mid-cap sponsor client base.

TypeBroad incumbent
Description

Medpace is a mid-to-large CRO providing full-service clinical development and regulatory services to small and mid-sized biotech sponsors. Comparable to Facet in target customer segment (emerging/small biotech) but broader in clinical operations capability.

3NAMSA
TypeDirect peer
Description

NAMSA is a medical-device-focused regulatory and testing services firm offering FDA submission strategy, biocompatibility, and clinical trial support. Comparable to Facet in medical device regulatory work, although NAMSA's in-house testing capabilities make it broader.

TypeBroad incumbent
Description

Parexel is a global CRO with a large regulatory affairs consulting practice serving biotech and large pharma across the full development lifecycle. Overlaps with Facet in regulatory strategy and submission services but operates at much greater scale and across multiple geographies.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with regulatory consulting, real-world evidence, and clinical development services. Overlaps with Facet in regulatory strategy for pharma/biotech but at vastly greater scale and with broader technology and analytics capabilities.

TypeDirect peer
Description

NDA Group is a regulatory affairs and product development consulting firm serving pharma and biotech clients with FDA submission and lifecycle strategy services. Highly comparable to Facet in service mix, customer profile (small-to-mid pharma), and consultative selling motion.

TypeBroad incumbent
Description

Charles River Laboratories is a CRO/CDMO offering regulatory and development services alongside nonclinical and manufacturing capabilities. Overlaps with Facet in regulatory strategy and FDA submission support, particularly for combination and biologic products.

TypeDirect peer
Description

ProPharma Group provides regulatory affairs, compliance, and pharmacovigilance consulting to pharma, biotech, and medical device companies. Comparable to Facet in regulatory consulting offerings, mid-market sponsor focus, and project-based engagement model.

TypeDirect peer
Description

Boyds Regulatory is a boutique regulatory affairs consultancy offering FDA/EMA submission strategy and clinical development support to biotech clients. Closely comparable to Facet in size, service scope, and emerging-biotech customer profile.

TypeBroad incumbent
Description

ICON plc is a global CRO offering regulatory consulting, clinical operations, and laboratory services across all major therapeutic areas. Comparable to Facet in regulatory consulting offerings but at substantially larger scale and global reach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Facet Life Sciences

Regulatory Affairs Consultingfacetlifesciences.com

Facet Life Sciences is a U.S.-based regulatory affairs and product development strategy consultancy serving small biotech, pharmaceutical, and medical device companies. It provides integrated advisory services spanning gap analysis, FDA meeting preparation, regulatory submissions, statistics, medical writing, and asset valuation, with specialty practices in ophthalmology, oncology, radiopharmaceuticals, psychedelics, and rare diseases.

What Facet Life Sciences does

Facet Life Sciences is a U.S.-based regulatory affairs and product development strategy consultancy founded in 2013 (originally as Virtual Regulatory Solutions, Inc., rebranded in 2014) and headquartered in Wayne, Pennsylvania. The firm serves small and emerging life sciences companies — primarily emerging biotech, small pharmaceutical developers, and medical device innovators — providing integrated advisory services from early preclinical planning through FDA approval, commercialization, and asset divestiture. Its service portfolio spans eight flagship offerings (US Agent Services, Gap Analysis, Strategic Regulatory and Development Guidance, FDA Meeting Consulting, Medical Writing of Submission Documents, Regulatory Submission Leadership, Strategic Statistical Services, and Asset Valuation and Optimization) plus specialty practices in ophthalmology, oncology, PET radiopharmaceuticals, psychedelic therapeutics, and rare/ultra-rare disease innovation.

The firm operates a virtual delivery model with 30+ employees distributed across 14 U.S. states, supported by a curated 20+ partner ecosystem that extends delivery into CMC manufacturing, clinical CRO operations (Lexitas for ophthalmology, Cannovation for psychedelics, Alithia for Australia, Veramed for biometrics), legal and IP, and the KIVO submission management platform (originally Gemstone, internally developed and later spun off as an independent software company). Revenue is generated exclusively through professional services engagements — project-based, retainer, or embedded-team structures — priced via custom scoping of regulatory, CMC, nonclinical, and clinical needs, with no published rate cards. The firm has supported more than 250 companies through FDA formal meetings and 40+ companies through IND/IDE, NDA/BLA, and device submissions.

The company's core technology is its accumulated institutional regulatory expertise rather than a proprietary software platform: proprietary gap analysis frameworks, integrated regulatory strategy methodologies, and 300+ years of combined team experience drawn from FDA-touching organizations (former leaders from Wyeth, Sanofi, Bristol-Myers Squibb, Eli Lilly, and Schering-Plough). Go-to-market is sales-led and consultative, targeting C-suite and executive leadership at small pharma and biotech companies; marketing relies on thought-leadership content (active blog, published Springer reference books, case studies), industry conferences (DIA, RAPS, SNMMI), and community engagement rather than paid acquisition. Distribution is entirely direct, U.S.-focused given the FDA regulatory specialization, with international reach delivered only through partner channels.

Facet Life Sciences firmographics

Firmographics
Name
Facet Life Sciences
Legal name
Facet Life Sciences
Website
https://facetlifesciences.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Facet Life Sciences is a U.S.-based regulatory affairs and product development strategy consultancy serving small biotech, pharmaceutical, and medical device companies. It provides integrated advisory services spanning gap analysis, FDA meeting preparation, regulatory submissions, statistics, medical writing, and asset valuation, with specialty practices in ophthalmology, oncology, radiopharmaceuticals, psychedelics, and rare diseases.
Ownership category
akta.pro rank

Facet Life Sciences industry classification

Industry
Product category
Regulatory Affairs Consulting
NAICS
Other Scientific and Technical Consulting Services (54169), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAIALAH
Regulatory Strategy & IND/NDA/BLA Submissions Support
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAKAL
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Regulatory affairs consulting
  • FDA submission strategy
  • Drug development consulting
  • Medical device regulatory
  • Biotech regulatory services

Where Facet Life Sciences is headquartered

Location

Headquarters

HQ city
Philadelphia
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Facet Life Sciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Regulatory Consulting and Advisory Services: Facet Life Sciences provides fee-for-service regulatory strategy, gap analysis, FDA meeting preparation, medical writing, regulatory submission leadership, and statistical consulting. Engagement models include project-based consulting, retainer arrangements, and embedded team support. Revenue is generated through professional service engagements billed by the project, hour, or program.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProject-based professional services — custom scoping

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Facet Life Sciences product offering

Product offering

Core offering

Facet Life Sciences is a regulatory affairs and product development strategy consulting firm that helps small biotech, emerging pharma, and medical device companies navigate FDA pathways from early development through approval and commercialization. Core engagements span US Agent Services, Gap Analysis, Strategic Regulatory & Development Guidance, FDA Meeting preparation, Medical Writing of regulatory submissions, Regulatory Submission Leadership (IND/IDE/NDA/BLA), Strategic Statistical Services, and Asset Valuation & Optimization, delivered on a project, retainer, or embedded-team basis.

Product overview

Facet Life Sciences is a regulatory affairs and product development strategy partner for small biotech and emerging science companies. The company offers a comprehensive suite of integrated advisory services organized around flagship service pillars: US Agent Services, Gap Analysis, Strategic Regulatory & Development Guidance, FDA Meeting Consulting, Medical Writing of Submission Documents, Regulatory Submission Leadership, Strategic Statistical Services, and Asset Valuation and Optimization. The company also maintains specialty expertise in Ophthalmology, Oncology, PET Radiopharmaceutical Development, Psychedelic Therapeutics, and Rare Disease Innovation Support. Beyond core services, Facet has developed proprietary technology (KIVO submission management platform, formerly Gemstone) and publishes educational content including the FDA and Intellectual Property Strategies for Medical Device Technologies book.

Differentiator

Problem solved

Functional benefit

Products and services

  • US Agent Services Liaises with the FDA on behalf of sponsors, serving as an experienced strategic US Agent that facilitates efficient collaboration and leverages decades of successful working relationships with FDA reviewers. Designed for non-US and emerging US companies that require a US-based regulatory point of contact with the FDA.
  • Gap Analysis Identifies program gaps, risks, and potential risk mitigation strategies for regulatory submissions across nonclinical, CMC, clinical, regulatory, and tactical dimensions. Used by emerging life sciences companies preparing for FDA meetings, INDs, NDAs, or device submissions.
  • Strategic Regulatory & Development Guidance Designs and executes effective regulatory, CMC, nonclinical, and clinical strategies that support end business goals, developing regulatory plans aligned with corporate objectives and resources. Targeted at small life sciences companies needing senior regulatory leadership without an in-house team.
  • FDA Meeting Consulting Prepares companies for FDA meetings through rigorous preparation processes, authoring meeting requests, background packages, and coaching to ensure productive interactions with FDA reviewers. Used by sponsors preparing Type A/B/C, pre-IND, EOP, and other formal FDA meetings.
  • Medical Writing of Submission Documents Authors and coordinates reviews for regulatory submissions on behalf of sponsors, including planning, preparation, QC, and finalization of documents written with the FDA reviewer in mind. Used by sponsors needing FDA-grade nonclinical, CMC, and clinical submission writing.
  • Regulatory Submission Leadership Manages creation, review, and finalization of regulatory submissions for new drug/biologic applications (IND, NDA, BLA), medical device applications, and combination products. Used by small companies needing outsourced regulatory operations leadership for major submissions.
  • Strategic Statistical Services Applies advanced statistical principles and methodologies to accelerate development of drugs, biologics, medical devices, and combination products through innovative study designs and cutting-edge analytic techniques. Targeted at sponsors needing expert biostatistics and biometrics support.
  • Asset Valuation and Optimization Helps companies know and grow the full potential of their asset at every development stage—from early-stage R&D through commercial launch—spanning market assessment, regulatory alignment, investor support, and pricing strategy. Used by emerging biotech and pharma teams preparing for investor outreach, partnerships, or divestiture.
  • Ophthalmic Drug Development Services Expert regulatory and development support for ophthalmology products including dry eye, glaucoma, meibomian gland dysfunction, wet AMD, uveitis, and rare ophthalmic diseases. Targeted at developers of ophthalmic drugs, biologics, devices, and combination products.
  • Oncology Drug Development Services

Quantifiable outcome

  • Pivotal study database lock to NDA (approved) in six weeks
  • +5 more outcomes

Companies that use Facet Life Sciences

Customer profile

Named customers6 records

Ideal customer profiles1 record

Facet Life Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Facet Life Sciences partnerships and signals

Strategic signal

Partnerships

21 partnerships are on record, tiered core and minor.

  • XCancercoreStrategic or Co-development Partner · 6 November 2025Facet Life Sciences and XCancer announced a strategic partnership to accelerate the development and approval of radiopharmaceutical therapies in oncology. The collaboration combines their expertise and infrastructure to streamline clinical trials and expand patient access to precision medicine. The partnership aims to simplify development and regulatory pathways for innovative theranostic therapies.
  • Nucleus RadioPharmacoreStrategic or Co-development PartnerNucleus RadioPharma is an end-to-end contract development and manufacturing organization (CDMO) partner dedicated to building robust and reliable clinical and commercial supply chains for targeted radiotherapies. Facet announced Nucleus as an official regulatory partner, providing clinical and commercial supply chain support for radiopharmaceutical programs.
  • Alithia Life SciencesminorChannel Partner/ Reseller/ DistributorAlithia Life Sciences is an Australian-owned boutique, full-service CRO launched to support pharmaceutical, biotechnology, device companies, and institutional research groups in the Australian region and beyond. Serves as Facet's regional partner for Australian clinical trial operations.
  • CannovationminorChannel Partner/ Reseller/ DistributorA U.S.-based global clinical research organization offering full-service preclinical/clinical research and commercialization services. Specializes in non-traditional cannabinoid and psychedelic-based drugs. Serves as Facet's partner for psychedelic and cannabinoid therapeutic development programs.
  • LexitasminorChannel Partner/ Reseller/ DistributorLexitas is a premier CRO dedicated exclusively to ophthalmology since 2011. Provides customized ophthalmic research solutions across all ophthalmology subspecialties. Serves as Facet's ophthalmology-specific clinical operations partner.
  • Theranostic TrialscoreStrategic or Co-development PartnerTheranosticTrials.org is the premier global hub advancing cancer Theranostics, connecting every link in the Theranostic Trials Ecosystem. Facet partners with Theranostic Trials to provide regulatory expertise as part of the theranostic clinical trial ecosystem, including for radioligand therapy development.
  • Tranquil Clinical ResearchminorChannel Partner/ Reseller/ DistributorTranquil Clinical Research provides clinical trial, device, and drug development process services with ethics and the patient in mind. Serves as Facet's partner for clinical trial execution support.
  • TrialwiseminorChannel Partner/ Reseller/ DistributorTrialwise specializes in early phases of drug development, founded in 1999 by Beth Brinsdon. Provides high-level personalized service for start-up and small-to-midsize biotech companies. Serves as Facet's partner for early-phase clinical development.
  • IDT AustraliaminorChannel Partner/ Reseller/ DistributorIDT Australia is an ASX-listed Contract Development and Manufacturing Organization (CDMO) based in Melbourne with over 50 years of experience in pharmaceutical manufacturing. Facilities audited by FDA, TGA, and Japanese MHLW. Serves as Facet's Australian manufacturing partner for oral and sterile injectable products.
  • RoyalMount Labs (Pharmascience Inc.)minorChannel Partner/ Reseller/ DistributorRoyalMount is a CDMO operating from an FDA-approved site in Candiac, Canada. Capabilities span small molecules, large molecules, oligonucleotides, monoclonal antibodies (mAbs), and antibody-drug conjugates (ADCs). Serves as Facet's Canadian manufacturing partner.
  • AsphalionminorChannel Partner/ Reseller/ DistributorAsphalion is a leading regulatory affairs consultancy founded in 2000, providing high-quality services for the development and registration of innovative drugs. Serves as Facet's ex-US regulatory affairs partner for European regulatory support.
  • cGMP ValidationminorChannel Partner/ Reseller/ DistributorcGMP Validation is a full-service validation/compliance firm established in 1997 serving pharmaceutical, biotech, biologics, medical device, and diagnostic industries. Provides validation IQ/OQ/PQ protocols and compliance documentation. Serves as Facet's GxP audit partner.
  • Troutman Pepper LockeminorOthersTroutman Pepper Locke is a global law firm helping clients solve complex legal challenges in life sciences, including regulatory, intellectual property, and corporate matters. Serves as Facet's legal counsel partner for complex client matters.
  • MedSurg PIminorChannel Partner/ Reseller/ DistributorMedSurg PI provides medical affairs services for pharmaceutical, biotechnology, medical device, and related technology companies. Founded and led by experienced clinician-executives with backgrounds in medicine, surgery, technology, product commercialization, and clinical development. Serves as Facet's medical affairs partner.
  • Attentive ScienceminorChannel Partner/ Reseller/ DistributorAttentive Science is an FDA-inspected, AAALAC-accredited premier global leader in GLP and non-GLP in-vivo pharmacokinetics, toxicology, and safety pharmacology services. Serves as Facet's nonclinical CRO partner.
  • NoscominorChannel Partner/ Reseller/ DistributorNosco is a full-service packaging solutions provider serving 400+ customers in healthcare with over 110 years of experience. Specializes in cartons, labels, inserts, and flexible packaging. Serves as Facet's packaging and printing partner.
  • Potomac Law GroupminorOthersPotomac Law is an intellectual property law firm with attorneys across the United States. Serves as Facet's patent support partner.
  • Volpe KoenigminorOthersVolpe Koenig is a full-service IP law firm serving U.S. and global clients across varied industries and technologies. Provides strategic intellectual property counseling to protect valuable portfolios and assets. Serves as Facet's additional patent support partner.
  • Red NucleusminorChannel Partner/ Reseller/ DistributorRed Nucleus is the premier provider of learning, performance, and process solutions for the life sciences industry with more than 500 full-time employees. Serves as Facet's regulatory publishing and commercial/R&D training partner.
  • WAYS Pharmaceutical ServicesminorChannel Partner/ Reseller/ DistributorWAYS Pharmaceutical Services helps biopharmaceutical organizations prepare and submit research documents and supporting data to health authorities worldwide. Serves as Facet's regulatory submission preparation and advisory partner.
  • VeramedminorChannel Partner/ Reseller/ DistributorVeramed is a pioneering CRO providing next-level biometrics support across the drug development lifecycle. Certified B Corp providing transparent and collaborative statistical and programming solutions. Serves as Facet's end-to-end biometrics and CDISC/SEND partner.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Facet Life Sciences competitors and assessment

Company assessment

Direct peers

  • Pharmalex: Pharmalex is a regulatory and pharmacovigilance consulting firm supporting biotech and pharma companies across FDA/EMA submissions, CMC, and clinical development. Directly comparable to Facet in regulatory services focus and small/mid-cap sponsor client base.
  • NAMSA: NAMSA is a medical-device-focused regulatory and testing services firm offering FDA submission strategy, biocompatibility, and clinical trial support. Comparable to Facet in medical device regulatory work, although NAMSA's in-house testing capabilities make it broader.
  • NDA Group: NDA Group is a regulatory affairs and product development consulting firm serving pharma and biotech clients with FDA submission and lifecycle strategy services. Highly comparable to Facet in service mix, customer profile (small-to-mid pharma), and consultative selling motion.
  • ProPharma Group: ProPharma Group provides regulatory affairs, compliance, and pharmacovigilance consulting to pharma, biotech, and medical device companies. Comparable to Facet in regulatory consulting offerings, mid-market sponsor focus, and project-based engagement model.
  • Boyds Regulatory: Boyds Regulatory is a boutique regulatory affairs consultancy offering FDA/EMA submission strategy and clinical development support to biotech clients. Closely comparable to Facet in size, service scope, and emerging-biotech customer profile.

Broad incumbents

  • Medpace Holdings: Medpace is a mid-to-large CRO providing full-service clinical development and regulatory services to small and mid-sized biotech sponsors. Comparable to Facet in target customer segment (emerging/small biotech) but broader in clinical operations capability.
  • Parexel International: Parexel is a global CRO with a large regulatory affairs consulting practice serving biotech and large pharma across the full development lifecycle. Overlaps with Facet in regulatory strategy and submission services but operates at much greater scale and across multiple geographies.
  • IQVIA: IQVIA is the world's largest CRO with regulatory consulting, real-world evidence, and clinical development services. Overlaps with Facet in regulatory strategy for pharma/biotech but at vastly greater scale and with broader technology and analytics capabilities.
  • Charles River Laboratories: Charles River Laboratories is a CRO/CDMO offering regulatory and development services alongside nonclinical and manufacturing capabilities. Overlaps with Facet in regulatory strategy and FDA submission support, particularly for combination and biologic products.
  • ICON plc: ICON plc is a global CRO offering regulatory consulting, clinical operations, and laboratory services across all major therapeutic areas. Comparable to Facet in regulatory consulting offerings but at substantially larger scale and global reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Facet Life Sciences social profiles

Digital presence

Facet Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Facet Life Sciences leadership team

Management profile

Number of profiles

Profiles8 records

Facet Life Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Facet Life Sciences M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Facet Life Sciences

What does Facet Life Sciences do?

Facet Life Sciences is a regulatory affairs and product development strategy consulting firm that helps small biotech, emerging pharma, and medical device companies navigate FDA pathways from early development through approval and commercialization. Core engagements span US Agent Services, Gap Analysis, Strategic Regulatory & Development Guidance, FDA Meeting preparation, Medical Writing of regulatory submissions, Regulatory Submission Leadership (IND/IDE/NDA/BLA), Strategic Statistical Services, and Asset Valuation & Optimization, delivered on a project, retainer, or embedded-team basis.

Is Facet Life Sciences a public or private company?

Facet Life Sciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Facet Life Sciences founded?

Facet Life Sciences was founded in 2013. It employs 11 to 50 people.

Where is Facet Life Sciences based?

Facet Life Sciences is headquartered in Philadelphia, United States, in the North America region.

How does Facet Life Sciences make money?

One revenue line is on record: regulatory Consulting and Advisory Services.

Who are Facet Life Sciences's main competitors?

Direct peers on record are Pharmalex, NAMSA, NDA Group, ProPharma Group and Boyds Regulatory. Broad incumbents are Medpace Holdings, Parexel International, IQVIA, Charles River Laboratories and ICON plc.

Does Facet Life Sciences have an API?

No public API is recorded for Facet Life Sciences.

What industry is Facet Life Sciences in?

Facet Life Sciences's product category is Regulatory Affairs Consulting. Its primary akta.pro industry code is HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA), with a secondary code of HLAIALAH, Regulatory Strategy & IND/NDA/BLA Submissions Support. Its NAICS code is 54169 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
citybizFacet Life Sciences Names Frank Closurdo VP of Commercial Services to Strengthen Regulatory and Market StrategyFacet Life Sciences has appointed Frank A. Closurdo as vice president of commercial services, a healthcare commercialization executive with over 20 years of experience across biopharmaceuticals, medical devices, and healthcare marketing. The appointment aims to help emerging biotechnology and pharmaceutical companies integrate commercial planning earlier in product development, aligning clinical trial design, regulatory strategy, and market requirements before committing significant resources. The hire supports Facet's broader strategy of providing integrated advisory services as life sciences companies face increasing pressure from investors and strategic partners to demonstrate commercial viability earlier in the product lifecycle.Business Wire BlogFacet Life Sciences Appoints Frank A. Closurdo as VP, Commercial Services, Strengthening Integrated Regulatory and Market GuidanceFacet Life Sciences appointed Frank A. Closurdo as Vice President, Commercial Services, bringing over two decades of experience in biopharmaceuticals and medical devices. He will focus on integrating commercial strategy earlier in development to align clinical protocols, regulatory expectations, and market considerations. The appointment reinforces Facet's position as a partner to emerging life sciences companies.MyChesCoFacet Life Sciences Releases Second Edition of Medical Device BookFacet Life Sciences has released the second edition of "FDA and Intellectual Property Strategies for Medical Device Technologies," an updated guide for medical device developers published by Springer International Publishing. The book addresses U.S. FDA regulatory requirements and intellectual property considerations for medical device approval, clearance, and commercialization, reflecting changes in technology and the regulatory environment. Six Facet Life Sciences employees contributed to the publication.MorningstarFacet Life Sciences and XCancer Announce Strategic Partnership to Advance Theranostic Clinical TrialsFacet Life Sciences and XCancer announced a strategic partnership to accelerate theranostic clinical trials in oncology. The collaboration combines Facet's regulatory expertise with XCancer's clinical trial network, aiming to streamline development and approval of radiopharmaceutical therapies.YahooFacet Life Sciences and XCancer Announce Strategic Partnership to Advance Theranostic Clinical TrialsFacet Life Sciences and XCancer announced a strategic partnership to accelerate development and approval of next-generation radiopharmaceutical therapies in oncology. The collaboration combines Facet's regulatory expertise with XCancer's clinical trial network, aiming to streamline pathways for precision diagnostics and therapeutics.PR NewswireFacet Life Sciences and XCancer Announce Strategic Partnership to Advance Theranostic Clinical TrialsFacet Life Sciences and XCancer announced a strategic partnership to accelerate the development and approval of next-generation radiopharmaceutical therapies in oncology. The collaboration integrates Facet's regulatory and drug development expertise with XCancer's theranostic clinical trial network and infrastructure to streamline pathways for sponsors. This alliance aims to remove barriers for clinical trial activation and expand patient access to precision medicine.FacetlifesciencesWhat Is HEOR? 8 Key Components for Smarter R&DThe article defines Health Economics and Outcomes Research (HEOR) as a scientific discipline combining health economics and outcomes research to inform healthcare decision-making. It outlines eight primary components, including cost-effectiveness analysis, budget impact analysis, and real-world evidence, explaining how these tools streamline drug development and optimize R&D spending. Facet Life Sciences is presented as a provider of HEOR expertise to help pharmaceutical companies make informed strategic decisions.YahooFacet Life Sciences Announces Partnership with Nucleus as Official Regulatory PartnerFacet Life Sciences announced its role as Nucleus's official regulatory partner for US FDA submissions. Facet's team has prepared over 40 radiopharmaceutical IND, NDA, BLA, and ANDA applications and led more than 75 FDA meetings. The partnership aims to support Nucleus's clients in advancing radiopharmaceutical products.PR NewswireFacet Life Sciences Announces Partnership with Nucleus as Official Regulatory PartnerFacet Life Sciences announced its role as Nucleus's official regulatory partner for US FDA submissions. Facet's team has prepared and submitted over 40 radiopharmaceutical IND, NDA, BLA, and ANDA applications, leading more than 75 FDA meetings. The partnership aims to guide Nucleus's clients through FDA approval processes.